Has there been a shift in how the European courts approach preliminary injunctions?
par Dr Paul England et Christoph de Coster, LL.M. (UC Davis)
AI driven drug design
Unpacking the role of AI in bringing new drugs to market.
par Dr Paul England
1 de 6 Publications
The EU torpedoes itself in cross-border patent disputes
par Dr Paul England
Paul England and Simon Cohen launch new life sciences IP guide
par Dr Paul England et Simon Cohen
Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies
par plusieurs auteurs
Edison Open House Global Healthcare 2021 – key takeaways from our panel
par plusieurs auteurs
Will the UK government's COVID-19 dosing regime gamble pay off?
par Alison Dennis et Justyna Ostrowska
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
par Alison Dennis
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
par Alison Dennis et Dr Paul England
Conférences et Webinars
Retrouvez les analyses de nos experts sur les dernières questions juridiques.
Voir tous les évènements
Has there been a shift in how the European courts approach preliminary injunctions?
par Dr Paul England et Christoph de Coster, LL.M. (UC Davis)
AI driven drug design
Unpacking the role of AI in bringing new drugs to market.
par Dr Paul England
1 de 6 Publications
The EU torpedoes itself in cross-border patent disputes
par Dr Paul England
Paul England and Simon Cohen launch new life sciences IP guide
par Dr Paul England et Simon Cohen
Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies
par plusieurs auteurs
Edison Open House Global Healthcare 2021 – key takeaways from our panel
par plusieurs auteurs
Will the UK government's COVID-19 dosing regime gamble pay off?
par Alison Dennis et Justyna Ostrowska
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
par Alison Dennis
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
par Alison Dennis et Dr Paul England